Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

Patna: Despite achieving more than 75% immunisation coverage for most vaccines, Bihar continues to struggle with low coverage ...

Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials ...

The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

IAVI and Biofabri are collaborating on the trial, which will recruit around 4,300 patients with latent TB infections across ...

Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.

Researchers have engineered two mycobacterial strains with built-in kill switches that trigger self-destruction after immune ...

ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...

Innovative research at Weill Cornell Medicine introduces engineered mycobacteria strains with 'kill switches' for safer TB ...